No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon β1b therapy in relapsing–remitting multiple sclerosis (the ARIANNA study)

Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial

(2014) Jeremy Chataway et al.   LANCET

Atorvastatin Added to Interferon Beta for Relapsing Multiple Sclerosis: 12-Month Treatment Extension of the Randomized Multicenter SWABIMS Trial

(2014) Christian P. Kamm et al.   PLoS One

Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial

(2011) Per Soelberg Sorensen et al.   LANCET NEUROLOGY

Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing–remitting multiple sclerosis

(2011) M Calabrese et al.   Multiple Sclerosis Journal

Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial

(2010) Mansoureh Togha et al.   Multiple Sclerosis Journal

Atorvastatin Combined To Interferon to Verify the Efficacy (ACTIVE) in relapsing— remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy

(2010) Roberta Lanzillo et al.   Multiple Sclerosis Journal

Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes

(2010) N. De Stefano et al.   NEUROLOGY

A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis

(2009) X. Montalban et al.   Multiple Sclerosis Journal

Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a

(2009) R. A. Rudick et al.   NEUROLOGY

Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study

(2008) G Tedeschi et al.   Multiple Sclerosis Journal

Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis

(2008) G. Birnbaum et al.   NEUROLOGY

Oral High-Dose Atorvastatin Treatment in Relapsing-Remitting Multiple Sclerosis

(2008) Friedemann Paul et al.   PLoS One